• FR
  • Donate
  • About
    • What is ARSACS?
    • Our Mission
    • What We Do
    • Our Team
      • Founders
      • Board of Directors
      • Researchers
  • Persons with ARSACS
    • International Patient Registry
    • Frequently Asked Questions
    • Patient Participation
      • Research Study
      • Preclinical and Clinical Trials
    • Connect with ARSACS Community
    • ARSACS Exercise Program at Home
  • Research
    • Research Projects
    • Research Grants
    • Research Tools
    • Partnerships
    • Publications
  • How You Can Help
  • Conferences & Events
    • 2026 International ARSACS Symposium
    • Past Conferences
  • News
  • Contact

Sacsin deletion decreases cell viscoelasticity and motility in a glial cell model of autosomal recessive spastic ataxia of Charlevoix Saguenay

Jul 1, 2025 | Publications

Sacsin deletion decreases cell viscoelasticity and motility in a glial cell model of autosomal recessive spastic ataxia of Charlevoix Saguenay – Dr. Federico Herrera. Based on the work of Dr. Federico Herrera and colleagues, published in July 2025 in Archives of Biochemistry and Biophysics..

Running in support of families affected by ARSACS

Running in support of families affected by ARSACS

Apr 8, 2026 | Latest News

read more...

Dimethyl Fumarate Tested in an ARSACS Mouse Model

Mar 31, 2026 | Research Project Reports

read more...
Newsletter #6  Winter 2026 Edition

Newsletter #6 Winter 2026 Edition

Mar 12, 2026 | Latest News, Uncategorized

read more...
« Older Entries


Location

1000 Sherbrooke O, bur. 2100, Montréal, QC H3A 3G4



Contact

1 (514) 370-3625
ataxie@arsacs.com

Contact Ataxia Charlevoix-Saguenay Foundation

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Copyright © 2026, Ataxia Charlevoix-Saguenay Foundation | Privacy Policy | 856980321RR0001

  • Follow
  • Follow